Skip to search formSkip to main contentSkip to account menu

A 81988

Known as: A-81988, A81988, Abbott-81988 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Angiotensin II Type 1 Receptor BlockersNicotinic AcidsTetrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Crystal structure of the alcoholates and the ansolvate of PNU-97018, an angiotensin II receptor antagonist.
The title compound, PNU-97018 [systemic name: 2-butyl-3,6,7,8,9,11-hexahydro-6,9-dimethyl-3-([2'-(2H-tetrazol-5-yl)[1,1'-biphenyl… 
1996
1996
Nitric Oxide and Angiotensin II Regulation of Renal Hemodynamics in the Developing Piglet
We have previously shown that nitric oxide (NO) is a more important intrarenal vasodilator in the developing animal compared with… 
1995
1995
Prevention by blockade of angiotensin subtype1‐receptors of the development of genetic hypertension but not its heritability
1 We determined whether early inhibition of angiotensin II subtype1 (AT1) receptors by the newly synthesized nonpeptidic… 
1994
1994
Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive rats.
ABBOTT-81988 (A-81988), 2-(N-propyl-N[(2'-[1H-tetrazol-5-yl]biphenyl- 4yl)methyl] amino) pyridine-3-carboxylic acid, a nonpeptide… 
1994
1994
[3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors.
1994
1994
Receptor interactions of Abbott-81988, a highly potent, non-peptide angiotensin-II antagonist selective for type-1 receptors.
Abbott-81988 (A-81988) was selected from a series of related compounds as a highly potent and selective antagonist of angiotensin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)